Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rijnders

Showing results (11-20 of 186) with videos related to

Pageof 19
Sort By:
The Netherlands Journal of Medicine|November 13, 2014
The new hepatitis C era: the guidelines are now available, reimbursement not yetS J Hullegie, B J A Rijnders
Lung Cancer (Amsterdam, Netherlands)|March 4, 2000
Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicateG Kramer, S Gans, A Rijnders, et al.
HIV Medicine|April 18, 2014
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapyC Rokx, A Verbon, B J A Rijnders
AIDS Research and Human Retroviruses|January 28, 2015
Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DFCasper Rokx, Annelies Verbon, Bart J A Rijnders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2019
Influenza and Invasive Aspergillosis in Immunocompromised PatientsAlbert Dunbar, Alexander Schauwvlieghe, Bart J A Rijnders
Pulmonary Pharmacology & Therapeutics|October 28, 2008
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trialLennert Slobbe, Eric Boersma, Bart J A Rijnders
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2022
Evidence-based dosing of convalescent plasma for COVID-19 in future trialsBart J A Rijnders, Sammy Huygens, Oriol Mitjà
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1990
Breast conserving treatment of Paget's diseaseP Bulens, L Vanuytsel, A Rijnders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1988
Practical implications of backscatter from outside the patient on the dose distribution during total body irradiationJ Van Dam, A Rijnders, L Vanuytsel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence?Bart J A Rijnders, Eric Van Wijngaerden, Willy E Peetermans
Pageof 19

Showing results (11-20 of 186) with videos related to

Sort By:
Pageof 19
The Netherlands Journal of Medicine|November 13, 2014
The new hepatitis C era: the guidelines are now available, reimbursement not yetS J Hullegie, B J A Rijnders
Lung Cancer (Amsterdam, Netherlands)|March 4, 2000
Long term survival of a patient with malignant pleural mesothelioma as a late complication of radiotherapy for Hodgkin's disease treated with 90yttrium-silicateG Kramer, S Gans, A Rijnders, et al.
HIV Medicine|April 18, 2014
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapyC Rokx, A Verbon, B J A Rijnders
AIDS Research and Human Retroviruses|January 28, 2015
Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DFCasper Rokx, Annelies Verbon, Bart J A Rijnders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 16, 2019
Influenza and Invasive Aspergillosis in Immunocompromised PatientsAlbert Dunbar, Alexander Schauwvlieghe, Bart J A Rijnders
Pulmonary Pharmacology & Therapeutics|October 28, 2008
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trialLennert Slobbe, Eric Boersma, Bart J A Rijnders
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2022
Evidence-based dosing of convalescent plasma for COVID-19 in future trialsBart J A Rijnders, Sammy Huygens, Oriol Mitjà
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1990
Breast conserving treatment of Paget's diseaseP Bulens, L Vanuytsel, A Rijnders, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 1, 1988
Practical implications of backscatter from outside the patient on the dose distribution during total body irradiationJ Van Dam, A Rijnders, L Vanuytsel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence?Bart J A Rijnders, Eric Van Wijngaerden, Willy E Peetermans
Pageof 19